BioNTech SE (WBO:BNTX) Tax Rate % : 30.96% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is BioNTech SE Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. BioNTech SE's Tax Expense for the three months ended in Dec. 2023 was €205 Mil. BioNTech SE's Pre-Tax Income for the three months ended in Dec. 2023 was €663 Mil. Therefore, BioNTech SE's Tax Rate % for the quarter that ended in Dec. 2023 was 30.96%.

BioNTech SE Tax Rate % Historical Data

The historical data trend for BioNTech SE's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Tax Rate % Chart

BioNTech SE Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Rate %

Get a 7-Day Free Trial

0.11

110.43

31.59

27.17

21.57

BioNTech SE Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Tax Rate %	Get a 7-Day Free Trial															28.18	29.04	53.81	29.38	30.96

BioNTech SE Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

BioNTech SE's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	255.8	/	1186.1
	=	21.57 %

BioNTech SE's Tax Rate % for the quarter that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (Q: Dec. 2023 )	/	Pre-Tax Income (Q: Dec. 2023 )
	=	205.3	/	663.2
	=	30.96 %

BioNTech SE Tax Rate % Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE (WBO:BNTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (WBO:BNTX) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

BNTX:USA BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil

Address

An der Goldgrube 12, Mainz, RP, DEU, D-55131

Website

https://www.biontech.de

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. COVID-19 vaccine Comirnaty is its first commercialized product.